Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Implication of Intermetatarsal Bursitis in Patients With Rheumatoid Arthritis

NCT05698563 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT05698563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05698563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Implication of Intermetatarsal Bursitis in Patients With Rheumatoid Arthritis
Lead sponsor
Rigshospitalet, Denmark
Phase
Not applicable
Overall status
Terminated
Start date
January 18, 2023
Completion date
December 12, 2024
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intermetatarsal bursitis, rheumatoid arthritis